|
|
|
|
BusinessWeek
--
While not an all-out success, Phase II testing of a Wyeth-Elan treatment showed positive results in a subset of patients. Investors applauded
The much anticipated results of a clinical trial of one of the more promising Alzheimer's drugs, released June..
Read More
|
|
|
BusinessWeek
--
AstraZeneca's Iressa took an FDA hit in 2005 as a lung cancer treatment, but a recent study showed its potential in breast cancer patients
There may be a second life for Iressa, AstraZeneca's once-promising cancer drug that came to symbolize the hype s..
Read More
|
|
|
BusinessWeek
--
The search giant's pilot program with the Cleveland Clinic is aimed at giving patients and doctors better access to electronic medical records
The U.S. health-care system is the most costly in the world. Yet it's also remarkably antiquated. The medical..
Read More
|
|
|
BusinessWeek
--
Research suggests that, except among high-risk heart patients, the benefits of statins such as Lipitor are overstated
Martin Winn's cholesterol level was inching up. Cycling up hills, he felt chest pain that might have been angina. So he and his doctor..
Read More
|
|
|
BusinessWeek
--
Shares fell Friday after the biotech announced unsuccessful clinical trial results for cancer drugs
Amgen (AMGN) has been fighting to prove that its colon cancer drug Vectibix can help save patients who are using a chemotherapy treatment in combination..
Read More
|
|
